CureVac Still Hopes Variants Could Win Favor For COVID-19 Vaccine

Trial Shows Overall Protection Rate Of 48%

 
• By Alaric DeArment
  
Doctor, nurse, scientist hand in blue gloves holding flu, measles, coronavirus, covid-19 vaccine disease preparing for child, baby, adult, man and woman vaccination shot, medicine and drug concept.
CureVac announced results of its HERALD study, showing a 48% overall protection rate, and 53% in the 18-60 group • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip